MedDataX Logo

Spinal Anesthesia Using Lidocaine and Sufentanil and (Transient Neurological Symptoms) TNS

NCT ID: NCT01283087

Last Updated: 2017-11-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

168 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-01-31

Study Completion Date

2016-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to find out whether patients receiving spinal anesthesia containing lidocaine and sufentanil get transient neurological symptoms.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Transient Neurologic Symptoms

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

TNS Spinal anesthesia Lidocaine

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* adults over the age of seventeen years

Exclusion Criteria

* patient refuse spinal anesthesia
* spinal anesthesia is contraindicated
* pregnancy
* patient is incapable of giving consent
* diabetes
* neurological disorders
* chronic pain
* chronic use of analgesics
* spinal anesthesia within five days before the actual surgery
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Vestre Viken Ringerike Sykehus

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Britt-Marie Berling

MD, PhD

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

halfdan Aas, MD, PhD

Role: STUDY_CHAIR

Vestre Viken HF

halfdan Aas, MD, PhD

Role: STUDY_CHAIR

VestreViken HF

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ringerike Sykehus

Hønefoss, , Norway

Site Status

Vestre Viken HF Ringerike Sykehus

Hønefoss, , Norway

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Norway

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

400229

Identifier Type: -

Identifier Source: org_study_id